Evidence map›Paper›PMID 34997010›Full record

ArticleScientific reports2022

Integrated bioinformatics and network pharmacology to identify the therapeutic target and molecular mechanisms of Huangqin decoction on ulcerative Colitis.

Yi Wu, Xinqiao Liu, Guiwei Li

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
16.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 99 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. From AI-AssistedPharmaceuticals (Basel, Switzerland) · 2025
    Review
  15. Arctigenin fromNutrients · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Yi WuFirst Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, 300000, China. wuyi_96@qq.com.
Xinqiao LiuFirst Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, 300000, China.
Guiwei LiFirst Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, 300000, China.
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine · CN

Funding

State Administration of Traditional Chinese Medicine of the People's Republic of China the 4th National Academic Experience Training Program of Famous Chinese Medicine Experts (Li Gui-wei) (Letter from the State Administration of TCM [2017]24)
6 · The paper itself

Abstract

Huangqin decoction (HQD) is a Traditional Chinese Medicine formula for ulcerative colitis. However, the pharmacology and molecular mechanism of HQD on ulcerative colitis is still unclear. Combined microarray analysis, network pharmacology, and molecular docking for revealing the therapeutic targets and molecular mechanism of HQD against ulcerative colitis. TCMSP, DrugBank, Swiss Target Prediction were utilized to search the active components and effective targets of HQD. Ulcerative colitis effective targets were obtained by microarray data from the GEO database (GSE107499). Co-targets between HQD and ulcerative colitis are obtained by Draw Venn Diagram. PPI (Protein-protein interaction) network was constructed by the STRING database. To obtain the core target, topological analysis is exploited by Cytoscape 3.7.2. GO and KEGG enrichment pathway analysis was performed to Metascape platform, and molecular docking through Autodock Vina 1.1.2 finished. 161 active components with 486 effective targets of HQD were screened. 1542 ulcerative colitis effective targets were obtained with |Log

Indexed as

Computational BiologyNetwork PharmacologyScutellaria baicalensisSystems IntegrationAnti-Inflammatory AgentsColitis, UlcerativeColonCyclooxygenase 2CytokinesDatabases, GeneticDrugs, Chinese HerbalEstrogen Receptor alphaFlavanonesGastrointestinal AgentsGene Regulatory NetworksHumansAnti-Inflammatory AgentsbaicaleinCyclooxygenase 2CytokinesDrugs, Chinese HerbalESR1 protein, humanEstrogen Receptor alphaFlavanonesGastrointestinal AgentsPPAR gammaPPARG protein, humanPTGS2 protein, humanQuercetinwogonin

Identifiers

PMID34997010
PMCPMC8741777
OpenAlexW4205315629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.